Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hims

Hims
2017 FOUNDED
PRIVATE STATUS
51-60 EMPLOYEES
Series C LATEST DEAL TYPE
$100M LATEST DEAL AMOUNT
18 INVESTORS
Description

Provider of an online platform intended to offer for sale wellness products for men. The company's platform offers sexual wellness products, skin care and hair loss treatments to address problems like baldness, erectile dysfunction, skincare, nutrition and others that usually need a doctor's prescription to treat, despite being highly common, enabling men to find a cure for all of their day to day problems.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Internet Retail
Primary Office
  • 1 Letterman Drive, Building C
  • Suite 3500
  • San Francisco, CA 94129
  • United States

+1 (888) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Hims’s full profile, request a free trial.

Hims Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 28-Jan-2019 $100M 00000 00.00 Completed Generating Revenue
4. Early Stage VC (Series B2) 30-Sep-2018 0000 0000 00000 Completed Generating Revenue
3. Early Stage VC (Series B) 02-Mar-2018 0000 0000 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Nov-2017 $7M $7M 0000 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Hims Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B2 00,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B1 00,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A1 00,000,000 00.000000 00 00.00 00.00 00 00.00 00
Series A 52,590,567 $0.000001 8% $0.13 $0.13 1x $0.13 16.59%
Seed 11,010,363 $0.000001 8% $0 $0 1x $0 3.47%
To view this company’s complete Cap Table, request access »

Hims Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nutrafol Venture Capital-Backed New York, NY 0000 0000000000 0 0000
00000 Venture Capital-Backed New York, NY 0000 00000000000 0000
000000 00000000 Venture Capital-Backed Boulder, CO 00 00.000 0000000000 0 00.000
00000 Venture Capital-Backed New York, NY 0000 00000000000 0000
To view this company’s complete list of competitors, request access »

Hims Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
7 Global Capital Growth/Expansion Minority 000 0000 000000 0
8VC Venture Capital Minority 000 0000 000000 0
CAVU Venture Partners Venture Capital Minority 000 0000 000000 0
Founders Fund Venture Capital Minority 000 0000 000000 0
Maverick Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Hims Executive Team (4)

Name Title Board
Seat
Contact
Info
Andrew Dudum Founder & Chief Executive Officer
Spencer Lee Chief Financial Officer
Joe Spector Senior Vice President of Partnerships and Operations
Jack Abraham Co-Founder & Executive Chairman

Hims Board Members (1)

Name Representing Role Since Contact
Info
Jack Abraham Self Co-Founder & Executive Chairman 000 0000